Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

More Patients Set to Benefit as Kanghong Pharmaceutical Targets New Indications with Conbercept

prnasiaFebruary 04, 2021

Tag: Chengdu Kanghong , Conbercept , Lumitin , retinal disease

PharmaSources Customer Service